Controversial New Alzheimer’s Drug: What to Know

As the primary Alzheimer’s drug authorised since 2003, advocates applaud the choice. Critics say the approval was based mostly on insufficient proof that the drug works and balk on the price ticket of $56,000 a yr.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here